Turn Therapeutics Inc. (TTRX)

NASDAQ: TTRX · Real-Time Price · USD

6.93

+0.11 (1.61%)

At close: Jun 26, 2026, 4:00 PM EDT

6.86

-0.07 (-1.01%)

After-hours: Jun 26, 2026, 5:51 PM EDT

Turn Therapeutics Employees

Turn Therapeutics had 2 employees as of December 31, 2025. The number of employees decreased by 2 or -50.00% compared to the previous year.

Employees

2

Change

-2

Growth

-50.00%

Revenue / Employee

n/a

Profits / Employee

-$1,918,253

Market Cap

206.43M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)	Full-Time	Part-Time
Dec 31, 2025	2	-	-	2	0
Jun 30, 2025	2	-2	-50.00%	2	0
Jun 30, 2024	4	-	-	1	3
Dec 31, 2023	4	-	-	1	3

Related Stocks

Company Name	Employees
Cellectis	229
MediWound	121
Arcturus Therapeutics Holdings	111
Nkarta	108
Keros Therapeutics	87
Compugen	75
Unicycive Therapeutics	22
Canton Strategic Holdings	12

Employee Rankings

TTRX News

23 days ago - Turn Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
26 days ago - Turn announces interim analysis findings from Phase 2 trial of GX-03 - TheFly
26 days ago - Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis - Business Wire
4 weeks ago - Turn Therapeutics announces peer-reviewed article on GX-03 - TheFly
4 weeks ago - Turn Therapeutics Announces Peer-Reviewed Publication in Journal of Dermatological Treatment Highlighting GX-03 Activity in IL-36 Associated Inflammatory Model - Business Wire
5 weeks ago - Turn Therapeutics to Present at Jefferies Global Healthcare Conference 2026 - Business Wire
5 weeks ago - Turn appoints Hahn as Executive Clinical, Regulatory Lead for GX-03 - TheFly
5 weeks ago - Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead - Business Wire